Three Drug Manufacturers Earn Warning Letters for GMP Violations

Drug Industry Daily
A A
The FDA handed warning letters to three drug manufacturers, citing them for GMP violations that range from data integrity deficiencies to sterility control failures.

To View This Article:

Login

Subscribe To Drug Industry Daily